LF
GILD icon

Longbow Finance’s Gilead Sciences GILD Stock Holding History

Longbow Finance’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.59M Sell
44,208
-6,546
-13% -$862K 0.71% 51
2026
Q1 		$7.07M Buy
50,754
+6,287
+14% +$880K 1.28% 32
2025
Q4 		$5.46M Sell
44,467
-48,344
-52% -$5.88M 0.92% 42
2025
Q3 		$10.3M Buy
92,811
+24,044
+35% +$2.73M 1.02% 36
2025
Q2 		$7.62M Buy
68,767
+9,390
+16% +$999K 0.81% 42
2025
Q1 		$6.65M Buy
+59,377
New +$6.13M 0.8% 41

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Longbow Finance's GILD Position: Q2 2026 in Review

Longbow Finance reduced its Gilead Sciences (GILD) stake by 13% in Q2 2026, selling an estimated $862K and leaving 44,208 shares worth $5.59M. The position accounts for 0.71% of the portfolio, ranked #51.

Longbow Finance first reported a position in GILD in Q1 2025 and has held it in 6 quarters since. The position peaked at $10.3M in Q3 2025. 2,283 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Longbow Finance held 44,208 shares of Gilead Sciences worth $5.59M as of Q2 2026.
  • Longbow Finance sold 6,546 Gilead Sciences shares in Q2 2026, an estimated $862K.
  • Gilead Sciences made up 0.71% of Longbow Finance's portfolio in Q2 2026, its #51 holding.
  • Longbow Finance first reported a position in Gilead Sciences in Q1 2025 and has held it in 6 quarters since.
  • Longbow Finance's Gilead Sciences position peaked at $10.3M in Q3 2025.
  • 2,283 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Longbow Finance's 13F filing for Q2 2026, filed 29 Jul 2026.